Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.
- NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_assertion description "[Studies of glioma xenografts suggest that they may be amenable to gene therapy with cytotoxic genes, such as the proapoptotic Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.
- NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_assertion evidence source_evidence_literature NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.
- NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_assertion SIO_000772 17178885 NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.
- NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_assertion wasDerivedFrom befree-20140225 NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.
- NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_assertion wasGeneratedBy ECO_0000203 NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.